Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): William Fearon Added: 2 years ago
In this short interview, Dr William F Fearon (Stanford University School of Medicine, US) discusses the findings from the FAME3 trial. This multicenter, international, randomized, controlled noninferiority trial investigated whether fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease (CAD) will result in similar… View more
Author(s): Laura Meems Added: 11 months ago
ECO 23 - We are joined by Dr Laura Meems (University Medical Center Groningen, NL) to discuss the impacts of obesity on the outcomes of heart failure.In this interview, Dr Meems outlines the effects of obesity on the progression and management of heart failure and the available treatment options for patients in 2023.Interview Questions:How does obesity impact the progression and management of… View more
Author(s): Antonio Gutierrez , Sunil V Rao Added: 3 years ago
Current evidence-based therapies for ischemic heart disease include antithrombotic and antiplatelet medications that reduce the risk for ischemic outcomes such as myocardial infarction and stroke.1 Given their mechanism of action, bleeding is a risk with these agents, especially when combined with invasive procedures.2 In addition to overt bleeding, clinical trials of antithrombotic strategies… View more
Author(s): Suzanne J Baron , Robert P Giugliano Added: 3 years ago
Coronary artery disease remains the leading cause of death in the US and worldwide. Although the incidence of death due to coronary artery disease has declined over the last several years, the prevalence of coronary artery disease remains high, with the American Heart Association (AHA) estimating that over 81 million Americans suffer from cardiovascular disease and 2,200 people dying every day of… View more
Author(s): David Kandzari Added: 2 years ago
In this short video, Dr David E Kandzari (Piedmont Heart Institute, Atlanta, GA, US) discusses the easy outcomes from the OPTIMUM registry. The registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary artery disease (CAD) and are deemed ineligible for coronary artery bypass surgery. The findings, presented… View more
Author(s): David Morrow Added: 3 years ago
Risk stratification of patients with an acute coronary syndrome (ACS) starts on presentation and is a continuous process to predict those who are at high risk for further ischemic events or adverse outcomes. Among patients with non-ST-elevation myocardial infarction (NSTEMI), risk stratification begins with initial assessment to detect patients at immediate high risk. Subsequent evaluation is… View more